About the Webinar: 

Please join us to learn more about the value of precision health and genomics to support awareness and understanding of multi-cancer early detection and the benefits for patients and health care providers eligible to order the test.

     Learning Objectives

• Define the burden of late-stage cancer diagnosis
• Describe the unmet need surrounding non-screened cancers
• Identify the science of blood-based cancer signals
• Recognize the public health promise of multi-cancer early detection   

About the Speaker: 

Christina Clarke Dur, PhD, is Head of Epidemiology and a Senior Principal Clinical Scientist at GRAIL. Christina has dedicated her professional life to reducing the burden of cancer through prevention, early detection and population health approaches. Before coming to GRAIL five years ago, she was a principal investigator co-leading the SEER cancer registry in the San Francisco Bay Area and researching the epidemiology of breast cancer, melanoma and lymphoma at the Cancer Prevention Institute of California and the Stanford Cancer Institute. Christina holds a BS in biology from Duke University, an MPH in Epidemiology from Tulane University and a PhD in Epidemiology from the University of California, Berkeley.